[Federal Register Volume 76, Number 86 (Wednesday, May 4, 2011)]
[Notices]
[Page 25375]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-10853]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) Title 21 of the Code of Federal
Regulations (CFR), this is notice that on February 9, 2011, Rhodes
Technologies, 498 Washington Street, Coventry, Rhode Island 02816, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)................................. I
Methylphenidate (1724)....................................... II
Codeine (9050)............................................... II
Dihydrocodeine (9120)........................................ II
Oxycodone (9143)............................................. II
Hydromorphone (9150)......................................... II
Hydrocodone (9193)........................................... II
Oripavine (9330)............................................. II
Thebaine (9333).............................................. II
Oxymorphone (9652)........................................... II
Noroxymorphone (9668)........................................ II
Fentanyl (9801).............................................. II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for conversion and sale to dosage form manufacturers.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than July 5, 2011.
Dated: April 25, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-10853 Filed 5-3-11; 8:45 am]
BILLING CODE 4410-09-P